Fifth Third Bancorp
GBT

Fifth Third Bancorp’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Fifth Third Bancorp’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-62
Closed -$3K – 2290
2020
Q1 		$3K Hold
62
– – ﹤0.01% 1954
2019
Q4 		$5K Hold
62
– – ﹤0.01% 1965
2019
Q3 		$3K Buy
+62
New +$3.23K ﹤0.01% 2026
2019
Q2 		– Sell
-400
Closed -$21K – 2387
2019
Q1 		$21K Sell
400
-254
-39% -$12.5K ﹤0.01% 1573
2018
Q4 		$27K Buy
654
+254
+64% +$9.52K ﹤0.01% 1450
2018
Q3 		$15K Buy
+400
New +$17.7K ﹤0.01% 1730

Other funds holding GBT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fifth Third Bancorp's GBT Position: Q2 2020 in Review

Fifth Third Bancorp sold out of Global Blood Therapeutics, Inc. (GBT) in Q2 2020, closing a stake of 62 shares — an estimated $3K sold.

Fifth Third Bancorp first reported a position in GBT in Q3 2018 and held it in 6 quarters. The position peaked at $27K in Q4 2018. 253 funds tracked by Wall St. Rank hold GBT as of Q2 2020.

  • Fifth Third Bancorp reported no remaining Global Blood Therapeutics, Inc. position as of Q2 2020 after selling out during the quarter.
  • Fifth Third Bancorp sold 62 Global Blood Therapeutics, Inc. shares in Q2 2020, an estimated $3K.
  • Fifth Third Bancorp first reported a position in Global Blood Therapeutics, Inc. in Q3 2018 and held it in 6 quarters.
  • Fifth Third Bancorp's Global Blood Therapeutics, Inc. position peaked at $27K in Q4 2018.
  • 253 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q2 2020.

Based on Fifth Third Bancorp's 13F filing for Q2 2020, filed 5 Aug 2020.